Press Releases

CALIXAR appears in many different kinds of news where we display our expertise and technology throughout the world.

2020-04-27

CALIXAR enters into collaboration with Kobe University to explore stabilized native membrane protein dynamics in reconstituted membranes using fluorescence.

2020-03-10

Calixar launches new funding round to establish business strategy.

2020-02-13

CALIXAR enters into Cryo-EM collaboration with CBI/IGBMC to unlock structure-based drug design for challenging membrane protein targets.

2019-11-06

CALIXAR and COSMO BIO to conclude distribution agreement.

2019-05-20

Biotem enters into collaboration with Calixar for the development of therapeutic antibodies against membrane protein targets.

2019-04-29

Calixar signs exclusive licensing agreement with Regeneron on undisclosed therapeutic target.

2019-04-05

Calixar announces a collaborative research agreement with Thermo Fisher Scientific on multiple membrane proteins of high relevance to drug discovery.

2017-11-28

CALIXAR and ASTRAZENECA to publish new insight on KCC2 architecture and function in Scientific Reports.

2016-06-24

CALIXAR and University of Avignon to launch new research lab developing innovative chemistry for target discovery.

2015-12-04

CALIXAR and Biouniversa to publish unprecedented new insights on Pancreatic Ductal Adenocarcinoma (PDAC) in Nature Communications.

2015-02-23

CALIXAR raises €1 Million.

2014-10-20

CALIXAR and ASTON University collaboration on multidrug resistance targets.

2014-09-23

Major Breakthrough in Influenza Vaccines.

2014-06-16

New strategic compounds: CALIXAR to extend its portfolio of strategic compounds for complex pharmaceutical target isolation.

2013-10-01

ABL Strategic Marketing.

2012-06-18

CALIXAR closes an initial €875,000 funding round.